Utility Menu

Weekly Report from the Board Meeting at Holman Prison 9.28.16

Weekly Report from the Board Meeting at Holman Prison 9.28.16

Lawyers for Thomas Arthur filed an appeal with the 11th U.S. Circuit Court of Appeals. Arthur’s attorneys argued a federal judge in July prematurely dismissed Arthur’s challenge after misapplying a requirement for inmates to name an alternate execution method.
“Absent this court’s intervention, Mr. Arthur will soon be executed without having been afforded the chance to prove that Alabama’s method of execution is highly likely to subject him to agonizing pain,” lawyers for Arthur wrote.


The above was a quote from the Daily Journal as is the following: “Alabama is seeking to resume executions after a more-than-two-year lull as the state faced a scarcity of lethal injection drugs and ongoing litigation over the death penalty.”
Yes, there is ongoing litigation about the constitutionality of Alabama’s death penalty due to its use of jury override/Hurst and its execution protocol. Completely unaddressed is also the venue of its execution drugs. We do know that Alabama’s compounding pharmacies have refused to be complicit in state murder as have the large European pharmaceutical companies.


In Missouri a mysterious supplier which goes by the code name M7, and which has sold more than $125,000 worth of lethal chemicals to Missouri, said its identity shouldn’t be disclosed, because it has a First Amendment free-speech right to act in support of the death penalty on the basis of its political views. It is representing itself in a suit filed on behalf of Missouri inmates. M7 wants to avoid being “shamed”. Obviously some political views need shaming!


We encourage you to contact the Governor on behalf of Thomas Arthur whose execution date is November 3rd. You can call, write or email. Contact information is on our website http://governor.alabama.gov/contact/  as are the Talking Points. http://www.phadp.org/?q=alerts Thank you to all of you who have already done so!


                See you next week,
                                                             Esther